Recruiting Lymphoma Studies in Albert Lea
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Ra...
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive B-cell non-Hodgkin lymp...
About Lymphoma Clinical Trials in Albert Lea
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Albert Lea, MN. These studies are seeking a combined 153 participants. Research is being sponsored by Mayo Clinic. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Albert Lea — FAQ
Are there lymphoma clinical trials in Albert Lea?
Yes, there are 2 lymphoma clinical trials currently recruiting in Albert Lea, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albert Lea?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albert Lea research site will contact you about next steps.
Are clinical trials in Albert Lea free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albert Lea studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Albert Lea are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov